CHALLENGE ADVANCES HEALTH TECHNOLOGIES AND MEDICAL DEVICES IN THE MEDTECH SECTOR Building Better Futures for Health Reaches 11 Year Milestone
With
George Sidis, Managing Director,
IDE Group
Teneille Murray,
Innovation & Growth Lead
Medical Technology Association of Australia
Nick Northcott, Co-Founder & Executive Chairman
Eudaemon Technologies
SEGMENT
Filmed in Sydney | August 2026
In July IDE Group launched the 2027 Building Better Futures for Health (BBFH) Challenge, a program supporting early-stage MedTech innovators move from concept to commercialisation. Delivered with Medical Technology Association of Australia’s (MTAA) MedTech Compass, the 2027 program marks 10 years of impact.
Now in its 11th year, BBFH supports researchers, clinicians, entrepreneurs and early-stage ventures tackling urgent healthcare needs. Selected teams will pitch to industry experts, gaining feedback to strengthen commercial potential.
BBFH combines IDE Group’s commercial and technical expertise with MTAA’s sector knowledge to help high-potential innovators validate, develop and commercialise health technologies. Since 2018, it has become a key platform for Australian MedTech innovation.
Participants will compete for up to $40,000 in IDE Group services: a $30,000 jury prize and $10,000 People’s Choice Award. Finalists also receive tailored guidance from IDE Group’s engineers, designers and clinicians.
The winning team will join MedTech Compass, MTAA’s program supporting early-stage medical device and digital health ventures with regulation, reimbursement, investment and market access guidance.
Over the years several start-ups have reached maturation to enter or soon to enter the market such as the inaugural Building Better Futures for Health (BBFH) Winner 2016 Eudaemon Technologies.
Applications close 31 August 2026, followed by a Semi-Finalist Showcase on the 12 November 2026 in Sydney and the Grand Final at the MTAA MedTech Conference on 3 March 2027 in Sydney. To apply, please visit the BBFH Challenge website at www.ide.group/bbfh-challenge.
Source: Adapted from joint IDE Group and MTAA media release, July 2026
-
Investigating use of dietary supplements for osteoarthritis
Osteoarthritis is a leading cause of disability affecting over 2 million Australians, according to Australian Institute of Health and Welfare report on Chronic musculoskeletal conditions (2024) and 595 million people globally, according to BD 2021 Osteoarthritis Collaborators. Global, regional, and national burden of osteoarthritis, 1990–2020. It represents a significant public health burden that diminishes quality of life among ageing populations.
-
Confronting picture of growing women’s health crisis in uterine cancers
Uterine cancers have become Australia’s fastest-growing women’s cancer, with incidence doubling over the past 25 years and projected to continue to surge. Without immediate action, more than 44,000 women are expected to be diagnosed by 2035, and 8,900 will lose their lives to the disease.
Released November 2025, Australia’s first State of the Nation: Uterine Cancers in Australia 2025 report by the Australia New Zealand Gynaecological Oncology Group (ANZGOG), reveals a confronting picture of a growing women’s health crisis that has gone largely unseen and one that now requires immediate, coordinated national action.
-
Expansion of specialist training in regional & rural areas
Associate Professor Sanjay Jeganathan, Chair of the Council of Presidents of Medical Colleges (CPMC) states, ”Our rural and regional communities deserve the same access to specialist care as our cities. We’re seeing real results from our colleges’ commitment to rural training.”
